If you haven't signed up for a membership with us, now is the time. When you sign up for our membership or to one of our webinars, you are directly supporting our mission to educate about and advocate for psychedelic medicines. Furthermore, your membership fees help us directly fund our advocacy campaign "Canada Supports" plus you get the benefit of connecting with others within our community and access to our networking events and webinars.
Sign up for our membership and get access to all the events below!
Unprocessed trauma is the most significant yet often misunderstood roadblock to health and embodied wellness, underlying the vast majority of mental health, physical health, and addiction issues. In this webinar, we will cover the physiology of trauma—from how it shapes neural networks to its impact on our broader physiology, relationships, and society. You’ll learn how to better understand trauma in your own body and life, how to support others, the impact of having an emotionally safe space with other men, and the power of psychedelics to help resolve traumas of all types. If you’re on a healing journey, a therapist, an integration coach, a healthcare worker, a parent, or simply wish to grasp the vital relationship between trauma, psychedelics, and health, this webinar is for you.
The recording of this event will be made available for everyone who purchased a ticket and CPA members one week after the event. Thank you for your support
The Psychedelic Renaissance is upon us - join 3 powerhouse women directors & producers: Anya Oleksiuk, Haya Heji and Mercedes Grant to discuss their feature documentary with CPA Board member Dr. Pamela Kryskow.
The recording of this event will be made available for everyone who purchased a ticket and CPA members one week after the event. Thank you for your support
Canada overwhelmingly supports access to new regulations with polling numbers showcasing the need for change including, 78% of Canadians polled support or somewhat support a government that legalized psilocybin-assisted psychotherapy to improve the quality of life for terminally ill patients.
The Canadian Psychedelic Association and other experts from across Canada have been meeting with Members of Parliament, senior government officials, representatives from all parties, and national stakeholders over the past 10 months and encountered unanimous support for access to psilocybin therapy with a palliative diagnosis.
With public support at an all-time high, we are focusing on introducing evidence-informed regulations to officials at Health Canada. We come together with a group of key experts including palliative care professionals, therapists, MDs, non-profit supports, industry, medical and legal experts to communicate, petition, and deliver a regulatory framework that will transform the lives of Canadians who deserve access to medicine that can help them overcome their most debilitating mental anxieties.
Work with us, lend your support and help us create a new path for legal psilocybin-assisted therapy in Canada. #canadasupports
#psychedelicassociation
Our petition's first go is now over! We gathered close to 15,000 signatures and the petition has been read in the House of Commons this fall. Thank you for your support!
Stay tuned for a NEW petition as we won't stop this campaign until our voices have been heard in Ottawa and across Canada.
Thank you to Chris Bennett, Paul Manly, Kirk Tousaw, Rob Laurie, Jovian Francey, Trevor Millar, and others who started this petition process!
Curious about psychedelics and their potential for therapeutic and health benefits? Want to get plugged into the movement locally? Visit our Resources centre for books we recommend, films to watch, a global ecosystem map, training programs, and ongoing clinical trials.
Visit our resources centre
A membership based organization, the CPA aims to foster community conversation and collaboration for individuals interested in psychedelics and their promise across Canada. The CPA will bring the brightest and best in this field together to work through some of the unique challenges these substances face as they gain the mainstream acceptance and use they deserve.
.svg)
.svg)
.svg)
.svg)
